Key role of T cell defects in age-related vulnerability to West Nile virus

James D. Brien, Jennifer L. Uhrlaub, Alec Hirsch, Clayton A. Wiley, Janko Nikolich-Žugich

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

West Nile virus (WNV) infection causes a life-threatening meningoencephalitis that becomes increasingly more prevalent over the age of 50 and is 40-50x more prevalent in people over the age of 70, compared with adults under the age of 40. In a mouse model of age-related vulnerability to WNV, we demonstrate that death correlates with increased viral titers in the brain and that this loss of virus control with age was the result of defects in the CD4 and CD8 T cell response against WNV. Specific age-related defects in T cell responses against dominant WNV epitopes were detected at the level of cytokine and lytic granule production, each of which are essential for resistance against WNV, and in the ability to generate multifunctional anti-WNV effector T cells, which are believed to be critical for robust antiviral immunity. In contrast, at the peak of the response, old and adult T cells exhibited superimposable peptide sensitivity. Most importantly, although the adult CD4 or CD8 T cells readily protected immunodeficient mice upon adoptive transfer, old T cells of either subset were unable to provide WNV-specific protection. Consistent with a profound qualitative and quantitative defect in T cell immunity, old brains contained at least 12x fewer total effector CD8 T cells compared with adult mice at the peak of brain infection. These findings identify potential targets for immunomodulation and treatment to combat lethal WNV infection in the elderly.

Original languageEnglish (US)
Pages (from-to)2735-2745
Number of pages11
JournalJournal of Experimental Medicine
Volume206
Issue number12
DOIs
StatePublished - Nov 23 2009

Fingerprint

West Nile virus
T-Lymphocytes
Virus Diseases
Immunity
Brain
Meningoencephalitis
Immunomodulation
Adoptive Transfer
T-Lymphocyte Subsets
Antiviral Agents
Epitopes
Cytokines
Viruses
Peptides
Infection

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Key role of T cell defects in age-related vulnerability to West Nile virus. / Brien, James D.; Uhrlaub, Jennifer L.; Hirsch, Alec; Wiley, Clayton A.; Nikolich-Žugich, Janko.

In: Journal of Experimental Medicine, Vol. 206, No. 12, 23.11.2009, p. 2735-2745.

Research output: Contribution to journalArticle

Brien, James D. ; Uhrlaub, Jennifer L. ; Hirsch, Alec ; Wiley, Clayton A. ; Nikolich-Žugich, Janko. / Key role of T cell defects in age-related vulnerability to West Nile virus. In: Journal of Experimental Medicine. 2009 ; Vol. 206, No. 12. pp. 2735-2745.
@article{9065bd6dcef74c8b8cc48ee65140e932,
title = "Key role of T cell defects in age-related vulnerability to West Nile virus",
abstract = "West Nile virus (WNV) infection causes a life-threatening meningoencephalitis that becomes increasingly more prevalent over the age of 50 and is 40-50x more prevalent in people over the age of 70, compared with adults under the age of 40. In a mouse model of age-related vulnerability to WNV, we demonstrate that death correlates with increased viral titers in the brain and that this loss of virus control with age was the result of defects in the CD4 and CD8 T cell response against WNV. Specific age-related defects in T cell responses against dominant WNV epitopes were detected at the level of cytokine and lytic granule production, each of which are essential for resistance against WNV, and in the ability to generate multifunctional anti-WNV effector T cells, which are believed to be critical for robust antiviral immunity. In contrast, at the peak of the response, old and adult T cells exhibited superimposable peptide sensitivity. Most importantly, although the adult CD4 or CD8 T cells readily protected immunodeficient mice upon adoptive transfer, old T cells of either subset were unable to provide WNV-specific protection. Consistent with a profound qualitative and quantitative defect in T cell immunity, old brains contained at least 12x fewer total effector CD8 T cells compared with adult mice at the peak of brain infection. These findings identify potential targets for immunomodulation and treatment to combat lethal WNV infection in the elderly.",
author = "Brien, {James D.} and Uhrlaub, {Jennifer L.} and Alec Hirsch and Wiley, {Clayton A.} and Janko Nikolich-Žugich",
year = "2009",
month = "11",
day = "23",
doi = "10.1084/jem.20090222",
language = "English (US)",
volume = "206",
pages = "2735--2745",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "12",

}

TY - JOUR

T1 - Key role of T cell defects in age-related vulnerability to West Nile virus

AU - Brien, James D.

AU - Uhrlaub, Jennifer L.

AU - Hirsch, Alec

AU - Wiley, Clayton A.

AU - Nikolich-Žugich, Janko

PY - 2009/11/23

Y1 - 2009/11/23

N2 - West Nile virus (WNV) infection causes a life-threatening meningoencephalitis that becomes increasingly more prevalent over the age of 50 and is 40-50x more prevalent in people over the age of 70, compared with adults under the age of 40. In a mouse model of age-related vulnerability to WNV, we demonstrate that death correlates with increased viral titers in the brain and that this loss of virus control with age was the result of defects in the CD4 and CD8 T cell response against WNV. Specific age-related defects in T cell responses against dominant WNV epitopes were detected at the level of cytokine and lytic granule production, each of which are essential for resistance against WNV, and in the ability to generate multifunctional anti-WNV effector T cells, which are believed to be critical for robust antiviral immunity. In contrast, at the peak of the response, old and adult T cells exhibited superimposable peptide sensitivity. Most importantly, although the adult CD4 or CD8 T cells readily protected immunodeficient mice upon adoptive transfer, old T cells of either subset were unable to provide WNV-specific protection. Consistent with a profound qualitative and quantitative defect in T cell immunity, old brains contained at least 12x fewer total effector CD8 T cells compared with adult mice at the peak of brain infection. These findings identify potential targets for immunomodulation and treatment to combat lethal WNV infection in the elderly.

AB - West Nile virus (WNV) infection causes a life-threatening meningoencephalitis that becomes increasingly more prevalent over the age of 50 and is 40-50x more prevalent in people over the age of 70, compared with adults under the age of 40. In a mouse model of age-related vulnerability to WNV, we demonstrate that death correlates with increased viral titers in the brain and that this loss of virus control with age was the result of defects in the CD4 and CD8 T cell response against WNV. Specific age-related defects in T cell responses against dominant WNV epitopes were detected at the level of cytokine and lytic granule production, each of which are essential for resistance against WNV, and in the ability to generate multifunctional anti-WNV effector T cells, which are believed to be critical for robust antiviral immunity. In contrast, at the peak of the response, old and adult T cells exhibited superimposable peptide sensitivity. Most importantly, although the adult CD4 or CD8 T cells readily protected immunodeficient mice upon adoptive transfer, old T cells of either subset were unable to provide WNV-specific protection. Consistent with a profound qualitative and quantitative defect in T cell immunity, old brains contained at least 12x fewer total effector CD8 T cells compared with adult mice at the peak of brain infection. These findings identify potential targets for immunomodulation and treatment to combat lethal WNV infection in the elderly.

UR - http://www.scopus.com/inward/record.url?scp=73349101903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73349101903&partnerID=8YFLogxK

U2 - 10.1084/jem.20090222

DO - 10.1084/jem.20090222

M3 - Article

VL - 206

SP - 2735

EP - 2745

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 12

ER -